Webster Bank N. A. Sells 2,734 Shares of CVS Health Co. (NYSE:CVS)

Webster Bank N. A. trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 3.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 77,836 shares of the pharmacy operator’s stock after selling 2,734 shares during the quarter. Webster Bank N. A.’s holdings in CVS Health were worth $6,208,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Riverpoint Wealth Management Holdings LLC acquired a new stake in CVS Health during the fourth quarter worth about $218,000. Canoe Financial LP grew its stake in CVS Health by 95.1% during the fourth quarter. Canoe Financial LP now owns 1,762,629 shares of the pharmacy operator’s stock worth $139,177,000 after buying an additional 859,134 shares in the last quarter. Meritage Portfolio Management grew its stake in CVS Health by 30.6% during the fourth quarter. Meritage Portfolio Management now owns 66,322 shares of the pharmacy operator’s stock worth $5,237,000 after buying an additional 15,548 shares in the last quarter. Ancora Advisors LLC grew its stake in CVS Health by 17.5% during the third quarter. Ancora Advisors LLC now owns 457,267 shares of the pharmacy operator’s stock worth $31,926,000 after buying an additional 68,005 shares in the last quarter. Finally, Steph & Co. boosted its stake in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Edward J. Ludwig acquired 1,000 shares of the stock in a transaction that occurred on Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the purchase, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.24% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CVS. JPMorgan Chase & Co. reduced their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. UBS Group downgraded shares of CVS Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $85.00 to $60.00 in a research note on Thursday, May 2nd. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. SVB Leerink restated a “market perform” rating and issued a $60.00 price target (down from $87.00) on shares of CVS Health in a research note on Wednesday, May 1st. Finally, Bank of America dropped their price objective on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Eleven investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $75.05.

CVS Health Trading Up 1.2 %

Shares of NYSE:CVS traded up $0.70 during mid-day trading on Friday, hitting $59.06. The company had a trading volume of 14,343,538 shares, compared to its average volume of 11,322,786. The firm has a fifty day moving average price of $59.56 and a 200 day moving average price of $70.19. The company has a market capitalization of $74.14 billion, a PE ratio of 10.38, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the previous year, the business posted $2.20 EPS. As a group, research analysts forecast that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.